May 1, 2019 News, Press Releases

I skip doses.

My name is Angela Gonzalez and I am a 66-year-old resident of Bridgeport, Connecticut. I have COPD, a chronic issue for me that affects my daily life. It’s hard to breathe sometimes, which is why my doctor prescribed me inhalers. I have been on Advair Diskus and Breo Ellipta inhalers, both of which are produced by the drug corporation GlaxoSmithKline.

My doctor prescribed the Advair Diskus to me first, and I used the inhaler for years before ultimately switching to Breo. My insurance covers 80% of the cost, but I am still left to pay $45. However, sometimes the price is up to $450 for an inhaler when I enter the Medicare donut hole.

I now take Breo Ellipta, which costs the same price as the Advair. Because of the high price of my Breo, I skip doses. I have a hard time paying for my inhaler, and because I have to skip doses, it is harder for me to breathe. Sometimes, my whole body starts hurting.

If I weren’t able to cover my co-pay, I wouldn’t be able to access my inhalers at all. I don’t even want to think about that –– I know it would be terrible for my health. I rely on these GlaxoSmithKline inhalers to breathe, but sometimes I feel that the price of these drugs put that out of reach.

JOIN US

Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.